BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9132859)

  • 1. [Seroprevalence of B19 parvovirus infection in patients with acute polyarthritis].
    Campoy Reolid E; Casanova Rituerto A; Rodríguez Moreno J; Gómez Vaquero C; Ros Expósito S; Roig Escofet D
    Rev Clin Esp; 1996 Dec; 196(12):828-30. PubMed ID: 9132859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
    Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis for human parvovirus B19-polyarthritis: usefulness of empty particle B19.ELISA and B19-DNA.PCR].
    Hatakeyama Y; Ishii K; Murai C; Sugamura K; Mitomo N; Saitoh T; Rikimaru Y; Okazaki T; Sasaki T
    Ryumachi; 1998 Oct; 38(5):689-95. PubMed ID: 9852745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
    Kerr JR; Coyle PV; DeLeys RJ; Patterson CC
    J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
    Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
    Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
    Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
    J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
    Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parvovirus B19 infection in children: uncommon clinical presentations.
    Barash J; Dushnitzky D; Sthoeger D; Bardenstein R; Barak Y
    Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
    Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
    Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
    Mata Rebón M; Bartolomé Husson C; Bernárdez Hermida I
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute polyarthritis associated with parvovirus B19 infection].
    Manero Ruiz FJ; Omeñaca Terés M; Pardo Aznar C; Manero Ruiz I
    An Med Interna; 2000 Mar; 17(3):153-4. PubMed ID: 10804640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 infection in children with acute illness and rash.
    Pruksachatkunakorn C; Apichartpiyakul N; Kanjanaratanakorn K
    Pediatr Dermatol; 2006; 23(3):216-8. PubMed ID: 16780465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
    Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
    J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus-like presentation of parvovirus B19 infection.
    Sève P; Ferry T; Koenig M; Cathebras P; Rousset H; Broussolle C
    Semin Arthritis Rheum; 2005 Feb; 34(4):642-8. PubMed ID: 15692957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.